Nachrichten zur DEPOMED INC. Aktie

DPO: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

Depomeds (DEPO) CEO Arthur Higgins on Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Jurys Still Out On Depomed

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Depomed Inc.s Shares Soared 23.2% Higher

The company rewarded investors with good news today....…

Depomeds (DEPO) CEO Arthur Higgins on Q1 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Depomed Q1 Earnings Per Share $0.48

* Q1 EARNINGS PER SHARE VIEW $0.17 -- THOMSON REUTERS I/B/E/S...…

Depomed Inc. 2018 Q1 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Depomed Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Quotidian Technical Highlights on Selected Drug Makers Stocks -- Amarin, Apricus Biosciences, Depomed, and DURECT

NEW YORK, April 25, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the…

Quotidian Technical Highlights on Selected Drug Makers Stocks -- Depomed, DURECT, Endo, and Ionis Pharma

NEW YORK, March 26, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. …

Depomeds (DEPO) CEO Arthur Higgins on Q4 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heres Why Depomed Inc Fell as Much as 13.8% Today

The company announced full-year 2017 earnings yesterday after the market closed....…

BRIEF-Depomed Reports Q4 GAAP Loss Per Share $0.52

* ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS...…

Technical Perspectives on Drug Makers Stocks -- Depomed, DURECT, Endo, and Ionis Pharma

NEW YORK, Feb. 21, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to…

Depomed (DEPO) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Depomed Announces Closing Of Nucynta Commercialization Agreement With Collegium Pharmaceutical

* DEPOMED ANNOUNCES CLOSING OF NUCYNTA COMMERCIALIZATION AGREEMENT WITH COLLEGIUM PHARMACEUTICAL...…

This Mornings Technical Outlook on Drug Makers Stocks -- Synergy Pharma, Depomed, United Therapeutics, and Novo Nordisk

NEW YORK, Dec. 20, 2017 /PRNewswire/ -- In keeping with the commitment to dynamically provide members with…

Depomed (DEPO) Depomed Announces NUCYNTA Commercialization Agreement with Collegium Pharmaceutical Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Depomed Executes an Exit Strategy for Its Opioid Drug

The company hopes a restructuring of its business can help it get back on its feet....…

Collegium Pharmaceutical (COLL) Announces Nucynta Commercialization Agreement With Depomed - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Depomed (DEPO) Announces NUCYNTA Commercialization Agreement with Collegium Pharmaceutical - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

New Partnership for the Commercialization of Nucynta® in the U.S. Territory

AACHEN, Germany, December 5, 2017 /PRNewswire/ -- The Grünenthal Group announced today that Nucynta® (tapentadol)…

BRIEF-Depomed Announces Nucynta® Commercialization Agreement With Collegium Pharmaceutical

* DEPOMED ANNOUNCES NUCYNTA® COMMERCIALIZATION AGREEMENT WITH COLLEGIUM PHARMACEUTICAL...…

Depomed farms out Nucynta sales, will lay off 40% of company

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pre-Market Technical Recap on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, United Therapeutics, and Depomed

NEW YORK, November 15, 2017 /PRNewswire/ -- If you want a Stock Review on SGYP, NVO, UTHR,…

Depomed Inc. 2017 Q3 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Depomeds (DEPO) CEO Arthur Higgins on Q3 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Depomed reports 3Q loss

Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Depomed and Slán Medicinal Holdings announce strategic asset transactions

* Depomed and Slán Medicinal Holdings Ltd announce strategic asset transactions...…

PDL BioPharma Announces Settlement Agreement with Valeant

INCLINE VILLAGE, Nevada, Oct. 30, 2017 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) today announced that…

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Depomed, Inc. - DEPO

NEW YORK, Oct. 13, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of…

Drug Makers Stock Performance Review -- Apricus Biosciences, DURECT, Sucampo Pharma, and Depomed

NEW YORK, September 26, 2017 /PRNewswire/ -- If you want a Stock Review on APRI, DRRX, SCMP,…

Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 17th Lead Plaintiff Deadline in Securities Class Action Against Depomed, Inc. (DEPO)

NEW YORK, Sept. 21, 2017 /PRNewswire/ -- Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation…

DEPOMED INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Depomed, Inc. To Contact The Firm

NEW YORK, Sept. 20, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in…

RM LAW Announces Class Action Lawsuit Against Depomed, Inc.

BERWYN, Pa., Sept. 15, 2017 /PRNewswire-USNewswire/ -- RM LAW, P.C. announces that a class action lawsuit has been filed on…

Depomed, Inc. (DEPO) Presents at the Morgan Stanley 2017 Global Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Depomed, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, Calif., Aug. 25, 2017 /PRNewswire/ -- Khang & Khang LLP (the "Firm") announces the filing of a securities class…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Depomed, Inc. of Class Action Lawsuit and Upcoming Deadline - DEPO

NEW YORK, Aug. 25, 2017 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Depomed, Inc.…

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Depomed, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, Aug. 24, 2017 /PRNewswire/ -- Lundin Law PC, a shareholder rights firm, announces the filing of a class…

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Depomed, Inc. (DEPO) & Lead Plaintiff Deadline: October 17, 2017

NEW YORK, Aug. 21, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action…

Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma

NEW YORK, August 16, 2017 /PRNewswire/ -- If you want a Stock Review on DEPO, SGYP, NVO,…

Why Avis Budget Group, Depomed, and Tenet Healthcare Slumped Today

These stocks helped drag the market lower. Find out why....…

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Depomed, Inc. (DEPO)

NEW YORK, Aug. 8, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf…

DEPOMED INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Depomed, Inc. To Contact The Firm

NEW YORK, Aug. 8, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential…